SCIENTURE HOLDINGS, INC. Debt Conversion, Converted Instrument, Amount
SCIENTURE HOLDINGS, INC. (SCNX) reported Debt Conversion, Converted Instrument, Amount of $75.00 thousand for the 0-month period ending 2019-10-31, per its 10-K filed 2021-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2021-03-29
- 2019-10-31: Debt Conversion, Converted Instrument, Amount 0 month $75.00K.
- 2015-09-30: Debt Conversion, Converted Instrument, Amount 9 month $0.00.
- 2014-09-30: Debt Conversion, Converted Instrument, Amount 9 month $576.42K.
| Period end | Debt Conversion, Converted Instrument, Amount 0 month | Debt Conversion, Converted Instrument, Amount 9 month |
|---|---|---|
| 2019-10-31 | $75.00K 10-K · filed 2021-03-29 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-02 | |
| 2014-09-30 | $576.42K 10-Q · filed 2015-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |